GlaxoSmithKline's Hasit Joshipura: Seeing a Healthy Future for India's Pharma Industry

GlaxoSmithKline (GSK) was among the first foreign pharmaceutical companies to enter India decades ago and is viewed "almost like an Indian company," according to Hasit Joshipura, vice president-south Asia and managing director for GSK in India. During an interview with India Knowledge@Wharton at the recent Wharton India Economic Forum in Philadelphia, Joshipura suggested that GSK's years of experience in India may soon pay significant dividends as it prepares to create a "branded generics portfolio, apart from our own pipeline, in emerging markets." He also spoke about the future of pharmaceutical regulation in India, which he believes will align more closely with Western models in terms of monitoring drug development and new product launches. Read the transcript at: http://knowledge.wharton.upenn.edu/india/article.cfm?articleid=4373